Cargando…

SARS-CoV-2 vaccines are well tolerated in patients with mastocytosis

Detalles Bibliográficos
Autores principales:	Tuncay, Gülseren, Bostan, Ozge Can, Damadoglu, Ebru, Karakaya, Gül, Kalyoncu, Ali Fuat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. 2022
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894735/ https://www.ncbi.nlm.nih.gov/pubmed/35257871 http://dx.doi.org/10.1016/j.anai.2022.02.026

Ejemplares similares

A practical method of drug provocation testing to prove tolerance to alternative drugs in drug hypersensitivity
por: DAMADOĞLU, Ebru, et al.
Publicado: (2021)

Cytokine Profiles of Chronic Urticaria Patients and The Effect of Omalizumab Treatment
por: Can Bostan, Ozge, et al.
Publicado: (2023)

Clinical Validation of the Spirohome Clinic Ultrasonic Spirometer in Child and Adolescent Patients
por: Sekerel, Bulent Enis, et al.
Publicado: (2022)

COVID-19 vaccination in the setting of mastocytosis—Pfizer-BioNTech mRNA vaccine is safe and well tolerated
por: Lazarinis, Nikolaos, et al.
Publicado: (2022)

Response to the letter to the editor: two cases of subacute thyroiditis after different types of SARS-CoV-2 vaccination
por: Bostan, Hayri, et al.
Publicado: (2022)

Phototoxic drug eruption induced by vandetanib used for the treatment of metastatic medullary thyroid cancer()
por: Bostan, Ecem, et al.
Publicado: (2022)

Reactivation of inflammatory monoarthritis during dupilumab treatment used for prurigo nodularis
por: Bostan, Ecem, et al.
Publicado: (2021)

A UK Survey Examining the Experience of Adults With Mastocytosis Receiving COVID-19 Vaccination
por: Sriskandarajah, Priya, et al.
Publicado: (2021)

Anaesthesia in a patient with mastocytosis
por: Maheshwari, Shivi, et al.
Publicado: (2022)

mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis
por: Rama, Tiago Azenha, et al.
Publicado: (2021)

Dermoscopic findings of pseudoxanthomatous mastocytosis localized on vulva
por: Li, Qiaofei, et al.
Publicado: (2018)

Bullous congenital diffuse cutaneous mastocytosis()()
por: Cardoso, Julia Marcon, et al.
Publicado: (2020)

Anesthetic experience in a pediatric patient with mastocytosis
por: Jo, Youn Yi, et al.
Publicado: (2011)

Transcriptomic profiling does not refine mastocytosis diagnosis
por: Buschhorn, Lars, et al.
Publicado: (2023)

Challenges in applying diagnostic criteria for systemic mastocytosis
por: Boggs, Nathan A., et al.
Publicado: (2023)

Systemic mastocytosis with an associated hematological neoplasms: One or two entities?
por: Njue, Linet, et al.
Publicado: (2020)

Two cases of subacute thyroiditis after different types of SARS-CoV-2 vaccination
por: Bostan, Hayri, et al.
Publicado: (2022)

Drugs and Vaccines Hypersensitivity in Children with Mastocytosis
por: Mori, Francesca, et al.
Publicado: (2022)

Congenital cutaneous mastocytosis mistaken for non‐accidental injury
por: Porter, Emma, et al.
Publicado: (2023)

Hyperacute Graft-Versus-Host Disease Mimicking Stevens-Johnson Syndrome in a Patient With Allogeneic Hematopoietic Stem Cell Transplantation
por: Bostan, Ecem, et al.
Publicado: (2022)

Mast cells derived from systemic mastocytosis exhibit an increased responsiveness to hyperosmolarity
por: Lyberg, Katarina, et al.
Publicado: (2022)

Engraftment in NSG(SCF) mice correlates with the WHO category and prognosis in systemic mastocytosis
por: Willmann, Michael, et al.
Publicado: (2023)

A protective AAV vaccine for SARS-CoV-2
por: Zhao, Simeng, et al.
Publicado: (2022)

Parsonage-Turner syndrome and SARS-CoV-2 vaccination
por: Sookaromdee, Pathum, et al.
Publicado: (2023)

Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinions
por: Valent, Peter, et al.
Publicado: (2020)

Melanoma and Mastocytosis
por: Vojvodic, Aleksandra, et al.
Publicado: (2019)

Evaluation of Antibody-Dependent Enhancement of SARS-CoV Infection in Rhesus Macaques Immunized with an Inactivated SARS-CoV Vaccine
por: Luo, Fan, et al.
Publicado: (2018)

Esophagitis and SARS-CoV-2 vaccine
por: Sriwijitalai, Won, et al.
Publicado: (2023)

Osteoporosis and Osteopathy Markers in Patients with Mastocytosis
por: Alpay Kanıtez, Nilüfer, et al.
Publicado: (2015)

Risk of appendicitis after SARS-CoV-2 infection and SARS-CoV-2 vaccination
por: Ljung, Rickard, et al.
Publicado: (2022)

Massive splenomegaly: flow cytometry as a diagnostic tool for systemic mastocytosis
por: Rastogi, Loveena, et al.
Publicado: (2018)

Liver fibrosis and its response to avapritinib in 2 patients with systemic mastocytosis
por: Cavazos, Karla, et al.
Publicado: (2022)

Are the new SARS-CoV-2 variants resistant against the vaccine?
por: Abdalla, Mohnad, et al.
Publicado: (2021)

A case of gross hematuria and IgA nephropathy flare-up following SARS-CoV-2 vaccination
por: Rahim, Shab E Gul, et al.
Publicado: (2021)

SARS-CoV-2 and the myths about vaccination()
por: Travezaño-Cabrera, Aaron, et al.
Publicado: (2021)

Immunophenotyping of SARS-CoV-2 and vaccine design
por: Cimolai, Nevio
Publicado: (2022)

Esophagitis and SARS-CoV-2 vaccine: Correspondence
por: Sriwijitalai, Won, et al.
Publicado: (2023)

Morphea after SARS-CoV2 vaccine()
por: Paolino, Giovanni, et al.
Publicado: (2023)

COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM)
por: Bonadonna, Patrizia, et al.
Publicado: (2021)

Antibody response to SARS-CoV-2 vaccines in patients with hematologic malignancies
por: Greenberger, Lee M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_092ftkap2uqfkn64c3nduoto16